Source: PLOS ONE. Unidades: FM, FMRP
Subjects: INFARTO DO MIOCÁRDIO, FIBRINA, CÉLULAS USO TERAPÊUTICO)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NAKAMUTA, Juliana S. et al. Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold. PLOS ONE, v. 4, n. 6, p. e6005, 2009Tradução . . Disponível em: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0006005. Acesso em: 30 set. 2024.APA
Nakamuta, J. S., Danoviz, M. E., Marques, F. L. N., Santos, L. dos, Becker, C., Gonçalves, G. A., et al. (2009). Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold. PLOS ONE, 4( 6), e6005. Recuperado de http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0006005NLM
Nakamuta JS, Danoviz ME, Marques FLN, Santos L dos, Becker C, Gonçalves GA, Vassallo PF, Schettert IT, Tucci PJF, Krieger JE. Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold [Internet]. PLOS ONE. 2009 ; 4( 6): e6005.[citado 2024 set. 30 ] Available from: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0006005Vancouver
Nakamuta JS, Danoviz ME, Marques FLN, Santos L dos, Becker C, Gonçalves GA, Vassallo PF, Schettert IT, Tucci PJF, Krieger JE. Cell therapy attenuates cardiac dysfunction post myocardial infarction: effect of timing, routes of injection and a fibrin scaffold [Internet]. PLOS ONE. 2009 ; 4( 6): e6005.[citado 2024 set. 30 ] Available from: http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0006005
